The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan
Abstract
Background —Structural and functional alterations of the vasculature may contribute to complications of hypertension. Because angiotensin II may be pivotal in some of these vascular abnormalities, we tested the hypothesis that the angiotensin type 1 (AT 1 ) receptor antagonist losartan, in contrast to the β-blocker atenolol, would correct resistance artery abnormalities in patients with essential hypertension. Methods and Results —Nineteen untreated patients with mild essential hypertension (47±2 years, range 30 to 65 years; 57% male) were randomly assigned in double-blind fashion to losartan or atenolol treatment for 1 year. Nine age/sex-matched normotensive subjects were also studied. Both treatments reduced blood pressure to a comparable degree (losartan, from 149±4.1/101±1.6 to 128±3.6/86±2.2 mm Hg, P <0.01; atenolol, from 150±4.0/99±1.2 to 130±3.2/84±1.4 mm Hg, P <0.01). Resistance arteries (luminal diameter 150 to 350 μm) dissected from gluteal subcutaneous biopsies were studied on a pressurized myograph. After 1 year of treatment, the ratio of the media width to lumen diameter of arteries from losartan-treated patients was significantly reduced (from 8.4±0.4% to 6.7±0.3%, P <0.01). Arteries from atenolol-treated patients exhibited no significant change (from 8.3±0.3% to 8.8±0.5% after treatment). Endothelium-dependent relaxation (acetylcholine-induced) was normalized by losartan (from 82.1±4.9% to 94.7±1.1%, P <0.01) but not by atenolol (from 80.4±2.7% to 81.7±4.6%). Endothelium-independent relaxation (by sodium nitroprusside) was unchanged after treatment. Conclusions —The AT 1 antagonist losartan corrected the altered structure and endothelial dysfunction of resistance arteries from patients with essential hypertension, whereas the β-blocker atenolol had no effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,980
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Structure and function of small arteries
Mulvany, M. J., & Aalkjaer, C. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.921 · Cited by 913
Lüscher, T. F., & Vanhoutte, P. M. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.344 · Cited by 878
Linder, L., Kiowski, W., Bühler, F. R., & Lüscher, T. F. (1990) · Circulation · doi:10.1161/01.cir.81.6.1762 · Cited by 798
Gibbons, G. H., Pratt, R. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115881 · Cited by 645
Small artery structure in hypertension. Dual processes of remodeling and growth.
Heagerty, A. M., Aalkjaer, C., Bund, S. J., Korsgaard, N., & Mulvany, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.391 · Cited by 645
(1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 554
Remodeling of cerebral arterioles in chronic hypertension.
Baumbach, G. L., & Heistad, D. D. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.968 · Cited by 494
Leri, A., Claudio, P. P., Li, Q., Wang, X., Reiss, K., Wang, S., Malhotra, A., Kajstura, J., & Anversa, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci316 · Cited by 456
Brush, J. E., Cannon, R. O., Schenke, W. H., Bonow, R. O., Leon, M. B., Maron, B. J., & Epstein, S. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192002 · Cited by 435
Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects
Hasdai, D., Gibbons, R. J., Holmes, D. R., Higano, S. T., & Lerman, A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3390 · Cited by 398
The loss of endothelium-dependent vascular relaxation in hypertension.
Lockette, W., Otsuka, Y., & Carretero, O. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii61 · Cited by 372
Siragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314
Aalkjaer, C., Heagerty, A. M., Petersen, K. K., Swales, J. D., & Mulvany, M. J. (1987) · Circulation Research · doi:10.1161/01.res.61.2.181 · Cited by 308
Thybo, N. K., Stephens, N., Cooper, A., Aalkjaer, C., Heagerty, A. M., & Mulvany, M. J. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.474 · Cited by 299
Preserved Endothelium-Dependent Vasodilatation in Patients with Essential Hypertension
Cockcroft, J. R., Chowienczyk, P. J., Benjamin, N., & Ritter, J. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301502 · Cited by 281
Schiffrin, E. L., Deng, L. Y., & Larochelle, P. (1994) · Hypertension · doi:10.1161/01.hyp.23.1.83 · Cited by 264
Self-citationMechanics and Composition of Human Subcutaneous Resistance Arteries in Essential Hypertension
Intengan, H. D., Deng, L. Y., Li, J. S., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.569 · Cited by 199
Self-citationThürmann, P. A., Kenedi, P., Schmidt, A., Harder, S., & Rietbrock, N. (1998) · Circulation · doi:10.1161/01.cir.98.19.2037 · Cited by 196
Schiffrin, E. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii1-a · Cited by 192
Self-citationSchiffrin, E. L., & Deng, L.-Y. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.699 · Cited by 192
Self-citationSchiffrin, E. L., & Deng, L. Y. (1996) · Journal of Hypertension · doi:10.1097/00004872-199610000-00014 · Cited by 182
Self-citationImprovement of Coronary Flow Reserve After Long-term Therapy With Enalapril
Motz, W., & Strauer, B. E. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1031 · Cited by 175
Histology of subcutaneous small arteries from patients with essential hypertension.
Korsgaard, N., Aalkjaer, C., Heagerty, A. M., Izzard, A. S., & Mulvany, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.523 · Cited by 174
Schiffrin, E. L., Deng, L.-Y., & Larochelle, P. M. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)96211-2 · Cited by 142
Self-citationSokolow, M., & Lyon, T. P. (2001) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2001.tb00129.x · Cited by 129
Touyz, R. M., He, G., Deng, L.-Y., & Schiffrin, E. L. (1999) · Circulation · doi:10.1161/01.cir.99.3.392 · Cited by 128
Self-citationRosei, E. A., Rizzoni, G., Castellano, M., et al. (1995) · PubMed · Cited by 117
Dose-dependent effects of perindopril on blood pressure and small-artery structure.
Thybo, N. K., Korsgaard, N., Eriksen, S., Christensen, K. L., & Mulvany, M. J. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.659 · Cited by 117
Rizzoni, D., Muiesan, M. L., Porteri, E., Castellano, M., Zulli, R., Bettoni, G., Salvetti, M., Monteduro, C., & Agabiti‐Rosei, E. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715020-00011 · Cited by 116
How to assess vascular remodelling in small and medium-sized muscular arteries in humans
Schiffrin, E. L., & Hayoz, D. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715060-00002 · Cited by 100
Self-citationLocalization of vascular resistance changes during hypertension.
Bohlen, H. G. (1986) · Hypertension · doi:10.1161/01.hyp.8.3.181 · Cited by 96
Deng, L.-Y., Li, J., & Schiffrin, E. L. (1995) · Clinical Science · doi:10.1042/cs0880611 · Cited by 96
Self-citationIn Vivo Study of AT1and AT2Angiotensin Receptors in Apoptosis in Rat Blood Vessels
Diep, Q. N., Li, J., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.617 · Cited by 95
Self-citationHuraux, C., Makita, T., Kurz, S. K., Yamaguchi, K., Szlam, F., Tarpey, M. M., Wilcox, J. N., Harrison, D. G., & Levy, J. H. (1999) · Circulation · doi:10.1161/01.cir.99.1.53 · Cited by 95
Effects of Losartan and Enalapril on Small Artery Structure in Hypertensive Rats
Rizzoni, D., Porteri, E., Piccoli, A., et al. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.305 · Cited by 86
Effect of AT1 Angiotensin-Receptor Blockade on Structure and Function of Small Arteries in SHR
Li, J.-S., Sharifi, A. M., & Schiffrin, E. L. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199707000-00011 · Cited by 85
Self-citationBénétos, A., Levy, B. I., Lacolley, P. J., Taillard, F., Duriez, M., & Safar, M. E. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3196 · Cited by 85
Schiffrin, E. L., Deng, L.-Y., & Larochelle, P. M. (1993) · PubMed · Cited by 83
Self-citationIn Vitro Responses of Human Peripheral Small Arteries in Hypercholesterolemia and Effects of Therapy
Goode, G., & Heagerty, A. M. (1995) · Circulation · doi:10.1161/01.cir.91.12.2898 · Cited by 70
Li, J.-S., & Schiffrin, E. L. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199607000-00011 · Cited by 60
Self-citationSchiffrin, E. L., & Deng, L. Y. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917030-00011 · Cited by 43
Self-citationLund‐Johansen, P., & Omvik, P. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029729 · Cited by 39
ez, J. D., Laviades, C., Mart??nez, E., Gil, M. J., Monreal, I., Fern??ndez, J., & Prìeto, J. (1995) · Journal of Hypertension · doi:10.1097/00004872-199503000-00011 · Cited by 31
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
The CAFE Investigators, CAFE Steering Committee and Writing Committee, Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A., Collier, D., Hughes, A. D., Thurston, H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.595496 · Cited by 1,645
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
The Vascular Endothelium and Human Diseases
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467
Metadata
- Authors
- Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M.
- Venue
- Circulation
- Published
- 2000-04-11
- Volume
- 101
- Issue
- 14
- Pages
- 1653-1659
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2082291507
- Cited by
- 616
- References
- 56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.